Vaxine Pty Ltd is a limited by shares, Australian proprietary company. This corporation was registered on 2002-06-05 and was issued with the 100787719 ACN. Its Australian Business Number is 95100787719. Since 2009-07-28, the company is headquartered in SA, post code 5042. The previous headquarters were located in ACT 2600 (from 2005-11-21 to 2009-07-28), ACT 2603 (from 2002-08-01 to 2005-11-21). Vaxine Pty Ltd was registered for the GST on 2002-08-01. Vaxine Pty Ltd has been using the Vaxine Pty Ltd trading name since 2002-08-01 (it has to be noted that the Australian Business Register no longer collects or updates trading names). In total the company used 1 trading name. The above data comes from the ABN database which was updated on 2009-07-29.
Status | From | To |
---|---|---|
Active | 2002-08-01 | current |
Name | From | To |
---|---|---|
Vaxine Pty Ltd | 2002-08-01 | current |
Name | From | To |
---|---|---|
Vaxine Pty Ltd | 2002-08-01 | current |
Location | From | To |
---|---|---|
SA 5042 | 2009-07-28 | current |
ACT 2600 | 2005-11-21 | 2009-07-28 |
ACT 2603 | 2002-08-01 | 2005-11-21 |
Status | From | To |
---|---|---|
Registered | 2002-08-01 | current |
Advertisements
General information:
Patent status: |
Filed The specification prior to acceptance and where the application has not lapsed |
Patent type: | NPE |
International Patent Classification:
IPC Mark: | A61K 31/715 |
Section code: | A - human necessities |
Class code: | 61 - medical or veterinary science; hygiene |
Subclass code: | K - preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l) |
Main group code: | 31 - medicinal preparations containing organic active ingredients |
Subgroup code: | 715 - polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; derivatives thereof, e.g. ethers, esters |
IP Australia process information:
Expiry date: | 2032-06-19 |
International Patent Classification:
IPC Mark: | A61P 37/06 |
Section code: | A - human necessities |
Class code: | 61 - medical or veterinary science; hygiene |
Subclass code: | P - specific therapeutic activity of chemical compounds or medicinal preparations |
Main group code: | 37 - drugs for immunological or allergic disorders |
Subgroup code: | 6 - immunosuppressants, e.g. drugs for graft rejection |
IP Australia process information:
Expiry date: | 2017-03-14 |
International Patent Classification:
IPC Mark: | A61K 39/39 |
Section code: | A - human necessities |
Class code: | 61 - medical or veterinary science; hygiene |
Subclass code: | K - preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l) |
Main group code: | 39 - medicinal preparations containing antigens or antibodies (materials for immunoassay g01n0033530000) |
Subgroup code: | 39 - characterised by the immunostimulating additives, e.g. chemical adjuvants |
IP Australia process information:
Expiry date: | 2009-08-17 |
Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.